Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Vincristine 3Methotrexate 3Mercaptopurine 3Etoposide 3Daunorubicin 3Cytarabine 3Cyclophosphamide 3Asparaginase 3Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Prednisolone 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Dexamethasone 2pegaspargase 1fludarabine 1etoposide phosphate 1blinatumomab 1aldesleukin 1Rituximab 1Prednisone 1Pirinitramide 1Morphine 1Interleukin-2 1Idarubicin 1Histamine 1Cladribine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm, Residual × Pirinitramide × Clear all
NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡